Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-26 @ 1:16 PM
Ignite Modification Date: 2025-12-26 @ 1:16 PM
NCT ID: NCT02416206
Description: None
Frequency Threshold: 5
Time Frame: Deaths were assessed up to 3 years. Adverse events were assessed up to 3 months
Study: NCT02416206
Study Brief: High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple Myeloma
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
BeEAM Bendaumustine, Etoposide, Cytrabine and Melphalan in autologous transplant for multiple myeloma BeEAM: BeEAM 5 None 48 65 17 65 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
neutropenic fever SYSTEMATIC_ASSESSMENT Investigations None View
Esophagitis SYSTEMATIC_ASSESSMENT Gastrointestinal disorders None View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
peripheral neuropathy SYSTEMATIC_ASSESSMENT Nervous system disorders None View
hypertension SYSTEMATIC_ASSESSMENT Cardiac disorders None View